Imbrium Therapeutics

Imbrium Therapeutics

Biotechnology, 201 Tresser BLVD, Stamford, Connecticut, 06901, United States, 11-50 Employees

imbriumthera.com

  • LinkedIn

phone no Phone Number: +12*********

Who is IMBRIUM THERAPEUTICS

Imbrium is a clinical-stage biopharmaceutical company dedicated to advancing medical science through the development of important new pharmacologic and biologic therapeutics. We are pursu...

Read More

map
  • 201 Tresser BLVD, Stamford, Connecticut, 06901, United States Headquarters: 201 Tresser BLVD, Stamford, Connecticut, 06901, United States
  • 2018 Date Founded: 2018
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 7311

checked-icon Does something look wrong? Fix it. | View contact records from IMBRIUM THERAPEUTICS

Imbrium Therapeutics Org Chart and Mapping

Employees

Priya Eddy

Assoc Director, Toxicology

Ellie H

Head of Biometrics

Rashmi Upasani

Director, Regulatory Strategy

Diane Kocot

Regulatory Affairs Specialist

Diane Kocot

Regulatory Affairs Specialist

Patricia Uhl

Associate Director, Mrl Operations

Evangeline Eddy

Assoc Director, Toxicology

D Boykin

Executive Administrative Assistant

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Imbrium Therapeutics

Answer: Imbrium Therapeutics's headquarters are located at 201 Tresser BLVD, Stamford, Connecticut, 06901, United States

Answer: Imbrium Therapeutics's phone number is +12*********

Answer: Imbrium Therapeutics's official website is https://imbriumthera.com

Answer: Imbrium Therapeutics's revenue is $1 Million to $5 Million

Answer: Imbrium Therapeutics's SIC: 7311

Answer: Imbrium Therapeutics has 11-50 employees

Answer: Imbrium Therapeutics is in Biotechnology

Answer: Imbrium Therapeutics contact info: Phone number: +12********* Website: https://imbriumthera.com

Answer: Imbrium is a clinical-stage biopharmaceutical company dedicated to advancing medical science through the development of important new pharmacologic and biologic therapeutics. We are pursuing oncology chemotherapeutics, treatments for disorders of the central nervous system, and non-opioid approaches to the management of pain. As an operating subsidiary of Purdue Pharma L.P., Imbrium strives to develop and bring to market new medicines that serve the unmet needs of patients, physicians and health systems worldwide. We have built a robust and diversified pipeline of investigational drug candidates, and we actively collaborate with industry and academic partners to identify and advance future impactful medicines. LinkedIn posts may include discussion of investigational products that have not been approved by FDA, and for which safety or effectiveness have not been established. There is no guarantee they will successfully complete development or gain FDA approval.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access